Omkar A. Deodhar

Array ( [id] => 2959955 [patent_doc_number] => 05273889 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-28 [patent_title] => 'Gamma-iterferon-leukotoxin gene fusions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 7/777715 [patent_app_country] => US [patent_app_date] => 1991-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 13304 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/273/05273889.pdf [firstpage_image] =>[orig_patent_app_number] => 777715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2937374 [patent_doc_number] => 05247070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-21 [patent_title] => 'N-terminal muteins of tumor necrosis factor' [patent_app_type] => 1 [patent_app_number] => 7/763512 [patent_app_country] => US [patent_app_date] => 1991-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22740 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/247/05247070.pdf [firstpage_image] =>[orig_patent_app_number] => 763512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2870732 [patent_doc_number] => 05162502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-10 [patent_title] => 'Modified trichokirin and their preparation for use in conjugates as inhibitors of protein synthesis' [patent_app_type] => 1 [patent_app_number] => 7/714870 [patent_app_country] => US [patent_app_date] => 1991-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3257 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/162/05162502.pdf [firstpage_image] =>[orig_patent_app_number] => 714870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2781661 [patent_doc_number] => 05130127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-14 [patent_title] => 'Human tumor therapy using beta (1-3) glucanlentinan and anti-tumor antibodies' [patent_app_type] => 1 [patent_app_number] => 7/707281 [patent_app_country] => US [patent_app_date] => 1991-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2457 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/130/05130127.pdf [firstpage_image] =>[orig_patent_app_number] => 707281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3016454 [patent_doc_number] => 05326559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-05 [patent_title] => 'Treatment of accelerated atheosclerosis with interleukin-2 receptor targeted molecules' [patent_app_type] => 1 [patent_app_number] => 7/701219 [patent_app_country] => US [patent_app_date] => 1991-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6867 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/326/05326559.pdf [firstpage_image] =>[orig_patent_app_number] => 701219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2963766 [patent_doc_number] => 05202118 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-13 [patent_title] => 'Method for promoting wound healing using IL-1' [patent_app_type] => 1 [patent_app_number] => 7/695860 [patent_app_country] => US [patent_app_date] => 1991-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 9387 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/202/05202118.pdf [firstpage_image] =>[orig_patent_app_number] => 695860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3411772 [patent_doc_number] => 05438121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-01 [patent_title] => 'Brain derived neurotrophic factor' [patent_app_type] => 1 [patent_app_number] => 7/691612 [patent_app_country] => US [patent_app_date] => 1991-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 68 [patent_no_of_words] => 47581 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/438/05438121.pdf [firstpage_image] =>[orig_patent_app_number] => 691612 [rel_patent_id] =>[rel_patent_doc_number] =>)